Ticker Hub
ABUS — AI Analysis & Sentiment
3 recent AI-generated analyses for ABUS. Sentiment and confidence insights updated continuously.
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B
FDA Fast Track for Imdusiran accelerates development and review, significantly enhancing Arbutus Biopharma's core pipeline value. This positive reg...
Apr 15, 2026Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update
Arbutus Biopharma's improved financial results and detailed Moderna settlement offer a significant cash infusion and pipeline validation, creating ...
Mar 23, 2026Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna
The $2.25 billion settlement with Moderna is transformative for Arbutus, significantly boosting its financial position.
Mar 3, 2026